The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Hallucinogens and Their Therapeutic Use: A Literature Review
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.
Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019
Classical psychedelics for the treatment of depression and anxiety: A systematic review.
Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019
Psychedelic microdosing benefits and challenges: an empirical codebook.
Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., ... & Hapke, E. | 10 July 2019 | Harm reduction journal
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., ... & Doblin, R. | Psychopharmacology | 7 May 2019
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
Rocha, J. M., Osório, F. L., Crippa, J. A. S., Bouso, J. C., Rossi, G. N., Hallak, J. E., & dos Santos, R. G. | Therapeutic advances in psychopharmacology | 26 April 2019
Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
Rodrigues, A. V., Almeida, F. J., & Vieira-Coelho, M. A. | Journal of psychoactive drugs | 25 April 2019
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
Coleman, J. A., Yang, D., Zhao, Z., Wen, P. C., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. | Nature | 24 April 2019
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).
Curry, D. W., Berro, L. F., Belkoff, A. R., Sulima, A., Rice, K. C., & Howell, L. L. | Neuropharmacology | 25 March 2019
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults
Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.
Wagner, A. C., Mithoefer, M. C., Mithoefer, A. T., & Monson, C. M. | Journal of psychoactive drugs | 19 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019
Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.
Dyck, E. | Journal of psychoactive drugs | 1 March 2019
A systematic study of microdosing psychedelics
Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., ... & Pogarell, O. | European archives of psychiatry and clinical neuroscience | 31 January 2019
Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD.
Barone, W., Beck, J., Mitsunaga-Whitten, M., & Perl, P. | Journal of psychoactive drugs | 7 January 2019
The effects of ketamine on suicidality across various formulations and study settings
Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018
Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
Kuypers, K. P., de la Torre, R., Farré, M., Xicota, L., Perna, E. D. S. F., Theunissen, E. L., & Ramaekers, J. G. | Scientific reports | 18 December 2018